CN1094355C - Yugan pill for curing hepatitis and ascites due to cirrhosis - Google Patents
Yugan pill for curing hepatitis and ascites due to cirrhosis Download PDFInfo
- Publication number
- CN1094355C CN1094355C CN00107173A CN00107173A CN1094355C CN 1094355 C CN1094355 C CN 1094355C CN 00107173 A CN00107173 A CN 00107173A CN 00107173 A CN00107173 A CN 00107173A CN 1094355 C CN1094355 C CN 1094355C
- Authority
- CN
- China
- Prior art keywords
- hepatitis
- medicinal pill
- pill
- examples
- yuganwan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicinal pill, namely Yuganwan, for treating various kinds of acute hepatitis, chronic hepatitis and hepatitis concurrent with cirrhotic ascites. The medicinal pill is mainly prepared by grinding traditional Chinese medicines with the functions of clearing heat and toxic materials, promoting blood generation, removing dampness by diuresis and removing jaundice into fine powder and making the powder into pills. The medicinal pill is characterized in that for treating acute hepatitis and chronic hepatitis, the raw materials comprise 20 to 60% of raw barley sprout, 10 to 40% of black alum and 5 to 25% of artemisia capillaris or rice bean; for treating hepatitis concurrent with cirrhotic ascites, 5 to 25% of polyporus or tuckahoe or water plantain or talcum is added to the raw materials. The medicinal pill has the advantages of high cure rate, high radical treatment, no toxic or side effect, short treatment period, low medicine expense and great popularization value.
Description
The present patent application is that I apply on June nineteen ninety-five 29, application number is that 95110516.7 name is called dividing an application of " Yuganwan-medicinal pill for hepatitis ".
The invention belongs to a kind of Chinese medicine pill for the treatment of various acute, chronic hepatitis and treatment hepatitis concurrent cirrhotic ascites.Simultaneously, dull yellowish colored skin, anemia also there is curative effect preferably.
Various hepatitis is a kind of commonly encountered diseases, frequently-occurring disease, and medicine is also a lot of, as glucuronolatone, interferon, polyinosini, liver must answer, MIEAOLING, hepatoprotective ball or the like.These medicines have the different curative effect of degree to control acute hepatitis and treatment chronic hepatitis.But the one, cure rate is low, radical-ability is poor; The 2nd, the drug price height, and treatment time is long, for the patient brings heavy financial burden.Particularly at treatment hepatitis concurrent cirrhosis ascites disease, effect is more undesirable.In recent years, China's performance Chinese medicine advantage, research and development are released many Chinese patent medicines and are used for the treatment of various hepatitis.As the compound recipe Liver Nourishing Pill that White Cloud Mountain, Tonghua, Jilin Province pharmaceutical factory produces, it is made up of 28 flavor Chinese medicines such as Radix Gentianae, Herba Taraxaci, Herba Sedi, Radix Salviae Miltiorrhizae, Radix Bupleuri, Radix Et Rhizoma Rhei.Cure mainly hepatitis B.This factory also produces a kind of strong liver regeneration ball, and its main component has Chinese medicines such as Fructus Amomi, Rhizoma Cyperi, Fructus Tsaoko, Cortex Cinnamomi, radix curcumae, Rhizoma Corydalis to make.Though these two kinds of new drugs have raising on curative effect, cure rate is still unsatisfactory, and continuously medicine time long, flavour of a drug are many, the medicine valency is still than higher; And have the anemia of pregnant woman to prohibit clothes, many limitation such as fasting raw food, maror during the medication, even also have side effect such as loose stool, nauseating, weak, stupor.
The objective of the invention is to overcome the deficiency that above-mentioned Chinese and western drugs is treated various hepatitis and cirrhosis ascites disease, a kind of curative effect height, strong, the very economical again Chinese medicine pill of short treating period---the Yuganwan-medicinal pill for hepatitis of radical-ability are provided.
The present invention is realized by following technical scheme, treat the Yuganwan-medicinal pill for hepatitis of various acute, chronic hepatitis, it is ground into the smalls pill and is formed by heat-clearing and toxic substances removing hemopoietic class, the drug matching of removing dampness and eliminating jaundice class, it is characterized in that its prescription and component content thereof are: select heat-clearing and toxic substances removing hemopoietic class Chinese medicine Fructus Hordei Germinatus, Alumen preparata two flavors for use, consumption is respectively 20~60% and 10~40%; Select removing dampness and eliminating jaundice class Chinese medicine for use, Herba Artemisiae Scopariae or Semen Phaseoli 5~25%.Be used for the treatment of the Yuganwan-medicinal pill for hepatitis of hepatitis concurrent cirrhosis ascites disease, it is characterized in that,, add diuretic eliminating dampness by diuresis class Chinese medicine Polyporus again as above-mentioned feature, or Poria or Rhizoma Alismatis or Talcum 5~25%, be ground into the smalls pill and form.
Heat-clearing and detoxifying herb Fructus Hordei Germinatus and Alumen preparata that the present invention selects for use, broken the similar medicine that the various hepatitis of traditional treatment is selected for use, this two flavors medicine not only has antipyretic and antidote functions, also have hemopoietic dampness removing, the digestant effect of strengthening the spleen and stomach, played antiviral, fall enzyme reason irritability, eliminated pain in the hepatic region and merit tired, anorexia.Used removing dampness and eliminating jaundice class Chinese medicine Herba Artemisiae Scopariae or Semen Phaseoli, can dampness removing jaundice eliminating, disperse the hot and suffocating outer fur that reaches, in let out damp and hot and swing turbid cause new.Play clearing heat secreting bile, the heat of going to become silted up, clear carbuncle stagnate, the function of regulating QI machine.The used Yuganwan-medicinal pill for hepatitis of cirrhotic ascites adds promoting diuresis to eliminate damp pathogen class Chinese medicine Polyporus or other three each of distinguishing the flavor of selected for use and mainly plays the effect of eliminating ascites, protecting the liver dampness removing.Because the said medicine that the present invention selects for use, not only noted heat-clearing and toxic substances removing, promptly kill patient's hepatitis virus, the more important thing is and noted overcoming the imbalance of each systemic-function of patient's human body internal organs and the disorder of liver and gall taste mechanism of qi, to strengthen the resistivity of patient's human body, hepatitis symptom and index are alleviated rapidly, remarkable to liver cirrhosis, hepatic ascites, jaundice therapeutic effect simultaneously.Because of antibody forms rapidly, and can strengthen the function of liver and gall taste, the combination that takes stopgap measures and effect a permanent cure is so Yuganwan-medicinal pill for hepatitis of the present invention has cure rate height, efficacy consolidation, is difficult for recurrence, radical-ability is strong, short treating period, instant effect, negative conversion rate advantages of higher.It has the blood circulation of improvement, the effect of hemopoietic dampness removing simultaneously, so dull yellowish colored skin, anemia are also had higher curative effect.And because used Chinese medicine is general Chinese herbal medicine, price is low, and flavour of a drug are few, so use its very economical.For the acute hepatitis patient, can cure a general course of treatment (30~40 days), and required expenses for medicine only picks up surplus yuan.Can cure general 2~3 courses of treatment of chronic hepatitis patient (60~90 days), and required expenses for medicine only is several ten yuan, promptly is that cirrhotic ascites its expenses for medicine general ten courses of treatment is also only used over one hundred unit.As seen value is low.This Yuganwan-medicinal pill for hepatitis is without any side effects in addition, and is also harmless with the medicine adapted of any other treating the liver inflammation.
The embodiment of the invention:
Treat the Yuganwan-medicinal pill for hepatitis prescription and the usage and dosage of various acute, chronic hepatitis: Fructus Hordei Germinatus 800 gram, Alumen preparata 150 grams, Herba Artemisiae Scopariae 150 grams are ground into smalls water and beat and be every gram one ball.One after each meal, every day three times, each 1~6 ball (gram).Dull yellowish colored skin, anemia are the same.
The Yuganwan-medicinal pill for hepatitis prescription and the usage and dosage of treatment cirrhotic ascites: Fructus Hordei Germinatus 800 gram, Alumen preparata 150 grams, Herba Artemisiae Scopariae 150 grams, Polyporus 250 grams are ground into smalls water and beat and be ball, taking medicine after meal every day three times, each 3~6 grams.
Various acute, chronic hepatitis 441 examples that my trial edition Yuganwan-medicinal pill for hepatitis treatment is once made a definite diagnosis.Acute hepatitis 256 examples wherein, acute icterohepatitisshock 124 examples in the middle of this, wherein male 74 examples, women 50 examples, 4~7 years old 24 examples, 8~15 years old 32 examples, 16~55 years old 68 examples; Acute no icterohepatitis 132 examples, wherein male 80 examples, women 52 examples.15~30 years old 36 examples, 31~55 years old 96 examples.Through a treatment in month, cure 225 examples in two kinds of acute hepatitises, account for 88%; Produce effects 12 examples account for 4.7%; 9 examples that take a turn for the better account for 3.4%; Change doctor's 10 examples midway, account for 3.9%.In chronic hepatitis 185 examples of accepting for medical treatment, wherein male 108 examples, women 77 examples; 15~30 years old 75 examples, 31~55 years old 110 examples through treatment in 3 months, are cured 150 examples, account for 81%, and produce effects 16 examples account for 8.7%; 5 examples that take a turn for the better account for 2.7%; Change doctor's 14 examples midway, account for 7.6%.
My Yuganwan-medicinal pill for hepatitis on probation tries treating the liver sclerosis ascites 300 examples, wherein male 230 examples, women 70 examples; 20~40 years old 30 people account for 10%; 40~62 years old 220 people account for 73%; 63~69 years old 50 people account for 17%.Through treatment in ten months, wherein cure 120 people, account for 40%; Produce effects 87 people account for 29%; 30 people that take a turn for the better account for 10%, and are invalid 63, account for 21%.
More than the therapeutic effect of two kinds of Yuganwan-medicinal pill for hepatitis on probation should say so gratifying.
Claims (2)
1, a kind of Yuganwan-medicinal pill for hepatitis for the treatment of the hepatitis concurrent cirrhotic ascites is characterized in that the medicament of being made by the composition of following consumption:
Fructus Hordei Germinatus 20-60% Alumen preparata 10-40% Herba Artemisiae Scopariae 5-25% Polyporus 5-25%.
2, Yuganwan-medicinal pill for hepatitis according to claim 1 is characterized in that being made by the composition of following consumption:
Fructus Hordei Germinatus 800 gram Alumen preparata 150 gram Herba Artemisiae Scopariaes 150 gram Polyporus 250 grams.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00107173A CN1094355C (en) | 2000-05-01 | 2000-05-01 | Yugan pill for curing hepatitis and ascites due to cirrhosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00107173A CN1094355C (en) | 2000-05-01 | 2000-05-01 | Yugan pill for curing hepatitis and ascites due to cirrhosis |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95110516A Division CN1060656C (en) | 1995-06-29 | 1995-06-29 | Yuganwan pill-medicine for hepatitis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1281705A CN1281705A (en) | 2001-01-31 |
CN1094355C true CN1094355C (en) | 2002-11-20 |
Family
ID=4578513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN00107173A Expired - Fee Related CN1094355C (en) | 2000-05-01 | 2000-05-01 | Yugan pill for curing hepatitis and ascites due to cirrhosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1094355C (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1079157A (en) * | 1993-03-20 | 1993-12-08 | 赵三立 | Medicine " Ganyanfukangling " for curing hepatitis |
CN1083723A (en) * | 1993-07-14 | 1994-03-16 | 邢炳荣 | A kind of Chinese medicine pill for the treatment of hepatitis B |
-
2000
- 2000-05-01 CN CN00107173A patent/CN1094355C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1079157A (en) * | 1993-03-20 | 1993-12-08 | 赵三立 | Medicine " Ganyanfukangling " for curing hepatitis |
CN1083723A (en) * | 1993-07-14 | 1994-03-16 | 邢炳荣 | A kind of Chinese medicine pill for the treatment of hepatitis B |
Also Published As
Publication number | Publication date |
---|---|
CN1281705A (en) | 2001-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1129577A (en) | Pellets for curing tinea | |
CN1328834A (en) | Capsule for curing cholecystitis | |
CN101703639A (en) | Damp-clearing and heat calming pill | |
CN102512632B (en) | Chinese herbal composition for treating abnormal menstruation | |
CN1332702C (en) | Medicine for treating psoriasis | |
CN101366903B (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
CN1054528C (en) | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" | |
CN1082376C (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
CN102988616A (en) | Chinese medicinal composition for treating anemia | |
CN1056064C (en) | Medicine for curing liver cancer and its making method | |
CN1557354A (en) | Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process | |
CN104873911B (en) | A kind of pyemic traditional Chinese medicine for oral administration of auxiliary treatment | |
CN104001131A (en) | Oral traditional Chinese medicine for preventing and treating stress ulcers | |
CN1094355C (en) | Yugan pill for curing hepatitis and ascites due to cirrhosis | |
CN102228624A (en) | Medicament for treating pharyngitis and preparation method thereof | |
CN102805847B (en) | Medicine for treating arthralgia | |
CN1162170C (en) | Leukoderma treating medicine and its prepn | |
CN1060656C (en) | Yuganwan pill-medicine for hepatitis | |
CN105362682A (en) | External-use medicine for treating hypomenorrhea | |
CN1333026A (en) | Medicine for treating hyperplasia of mammary glands | |
CN101204522B (en) | Pharmaceutical capsules for blood deficiency hypertension | |
CN1091026A (en) | Danshixiao medicine for treating cholelithiasis | |
CN100475262C (en) | Liver-soothing and qi-dispersing medicine for preventing and treating SARS and viral hepatitis complication | |
CN104784649A (en) | Traditional Chinese medicine decoction for treating scapulohumeral periarthritis | |
CN104524487A (en) | Traditional Chinese medicine capsule for treating gastric tumour and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1073126 Country of ref document: HK |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |